SUMMARY The humoral immune response to treatment with praziquantel (PZQ) was studied in eight patients with parenchymal cerebral cysticercosis (CC). In the serum and in the cerebrospinal fluid (CSF) before, during and after the administration of the drug, the following were quantitated (a) levels of specific anticysticercous antibodies measured in optical densities by the ELISA method; (b) levels of IgG, IgM, IgA and IgE; (c) levels of complement fraction C3, C4; (d) presence of immune complexes; (e) total number of white blood cells in the CSF. It was found that after treatment with PZQ, the level of specific anticysticercous antibodies and the level of IgG rose significantly in the CSF but not in the blood. The levels of the fractions of the complement and the immunoglobulins IgM, IgA and IgE did not change significantly either in the serum or in the CSF. The blood-brain barrier was found ruptured in three patients before therapy and in five patients after the therapy as measured by the albumin index. Nevertheless, the IgG index showed that there was local production of IgG in five patients before treatment and in seven after the end of it. The relative specific antibody index was greater than 1 0 in five patients before therapy and in seven after therapy. This data strongly supports the idea that the specific antibodies are produced intrathecally and are not derived from the serum pool through a ruptured blood-brain barrier. It was concluded that patients with parenchymal CC have an elevation of specific anticysticercous probably due to a combination of a ruptured bloodbrain barrier and intrathecal synthesis. The relatively small rupture ofthe blood-brain barrier and the high IgG and relative specific antibody index suggest that intrathecal synthesis is the most important mechanism. The humoral immune response may be of importance not only in the elimination of the parasite but also in the genesis of the illness.
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It is known that praziquantel (PZQ) is effective for parenchymal cerebral cysticercosis.27 We also know that during the administration ofthe drug we can find: (1) cerebrospinal fluid (CSF) pleocytosis; (2) worsening of symptoms such as headache and seizures suggestive ofcerebral parenchymal inflmmation; these symptoms fare better with the simultaneous administration of steroids; (3) computed tomography (CT) may show inflammation around the cysts; (4) some patients with parenchymatous cysticercosis while taking PZQ have developed hydrocephalus from arachnoiditis and obstruction of the subarachnoid space."27 These findings suggest that: (1) the exacerbation of clinical symptoms and the presence of an inflammatory CSF and cerebral parenchymal inflammation are due to parasite necrosis and lysis, induced by the drug with a great antigenic stimulus to the immune system with the consequent presence ofantibodies and cells at the site of inflammation; (2) the immune and inflammatory responses are probably related to the elimination of the parasite from the CNS. We postulated that the adequate explanation for these phenomena would probably involve increases in IgG, IgM, IgA or IgE; complement decrease and the possible appearance of immune complexes. If the immune reaction were confined to the CNS, the changes should be more conspicuous in CSF than in blood. On the other hand, ifthe immune reaction was generalised the changes should be detected in CSF and in blood.
Materials and methods
We prospectively studied eight patients with proven cerebral cysticercosis. All of them had parenchymal cysts and some had calcification and/or granulomas. The mean age of the patients was 37 years with a range from 25 A statistically significant increase of the titres of anticistercercous antibodies in CSF was found when we compared the titres before treatment with those titres at the end of it (p < 0 01) and after eight days of it (p < 0 01). There was no significant difference in serum concentrations of antibodies before and after treatment. IgG was increased in CSF at the end of the treatment with PZQ, and this was significant (p < 0.02). We did not find significant difference in blood. The rest of immunoglobulins did not show significant changes on their titres, in serum or in CSF. The complement did not show significant changes. In addition there was no significant appearance of immune complexes. The CSF white blood cells increased significantly after eight days oftreatment with PZQ (p < 0 01) (table 3), but not at the end of it. The total CSF protein was elevated in three and normal in five patients before treatment but was significantly elevated after the administration of the drug (p < 0.05) (table 3). All patients had a serum albumin within normal limits.
The CSF albumin/serum albumin ratio was normal Parenchymatous cysts and multiple granulomas 6 Parenchymatous cyst 7
Parenchymatous cysts and calcifications 8 Multiple parenchymatous cysts and granulomas in five of the eight patients before therapy but after therapy only one patient had a normal ratio ( We have shown that the sensitivity ofthe ELISA test is greater in patients with parasites in the subarachnoid space than in those cases in which the parasite is in the cerebral parenchyma.'0 Therefore, in those cases of subarachnoid cysticercosis or in those in which the cyst is near or inside the subarachnoid space, there is likely to be a considerable increase of antibodies titres'°in the CSF. It is somewhat perplexing that we did not find immune complexes in these patients, because we thought it was likely that the parasitic lysis with a major antigenic stimulus should have produced them. This may be due to the techniques used, to the low sensitivity ofour method, or to the distance of the parasite from the subarachnoid space. We did not find immune complexes either in the CSF or in the blood. The complement fractions did not change significantly, suggesting that there is no consumption of com- Humoral immune response in patients with cerebral parenchymal cysticercosis treated with praziquantel plement fractions in CSF; it suggests that an immune complex mediated disease is an unlikely cause of the inflammatory reaction. Again, this may be different in patients with subarachnoid cysts in whom the parasite is in direct contact with the CSFF. The immunoglobulins levels, IgM, IgA and IgE, did not change either in CSF or in blood, suggesting that these immunoglobulins do not take part importantly on the immune reaction that is seen during the treatment with PZQ.
Further studies are necessary to determine the immune response in patients with other types of cerebral cysticercosis. Apparently, the antibody increase take at least 15 days to be produced, and we do not know precisely its temporal course. All of our patients had high antibodies titres in CSF before treatment, but they rose significantly after it. Two important questions arise: is the blood brain barrier ruptured in these patients or does it rupture during treatment? Are the anticysticercous antibodies produced de novo intrathecally or they come from the blood? The total CSF protein was elevated in only three patients before and after treatment, although the mean protein level rose significantly after treatment. The CSF albumin/serum albumin ratio was significantly elevated in the three patients who had a high CSF protein level (patients 2, 6 and 7) and slightly elevated in three other patients. In two patients in whom the total CSF protein was normal and the CSF albumin/ serum albumin ratio was also normal, it could be demonstrated that de novo synthesis of IgG took place. Treatment with PZQ ruptured the blood-brain barrier in several patients.
The very high synthesis of intrathecal IgG and the presence of a high relative specific antibody index, along with the relatively small rupture of the bloodbrain barrier, as measured by the albumin index, suggests that intrathecal synthesis is the most important mechanism.
The role of the humoral immune response in the production of the disease remains controversial but this study suggests that antibody increase may be responsible for the antigen parasite elimination after the lysis produced by PZQ and, paradoxically, it may also enhance the associated inflammatory reaction. It is likely that it is also of importance in the genesis of the clinical symptoms observed during treatment with PZQ. The relative specific antibody index was significantly elevated (>0-01) in five patients before treatment and in seven patients after the end of the medication. This index is the best indication that specific antibodies are produced intrathecally.'-'7 This study suggests that most of the IgG produced intrathecally is specific. Specific antibody production inside the blood-brain barrier has been demonstrated in several infective processes of the nervous system, including mumps, meningitis" and herpes simplex infection of the nervous system.'5 In patients with measles encephalomyelitis, in whom no viral particles are found inside the central nervous system, no specific intrathecal antibody production has been demonstrated. 16 It is likely that specific intrathecal antibody production plays a role in several infective processes of the SNC including bacterial, viral and parasitic infections. '2 
